APT Medical

APT Medical Inc. is a high-tech enterprise specializing in the research, production, and sales of cardiac electrophysiology and interventional medical devices. It has formed a business layout led by a complete coronary pathway and cardiac electrophysiology medical devices, with peripheral vascular and neurointerventional medical devices as key development directions. Listed on the STAR Market of the Shanghai Stock Exchange on January 7, 2021, with the stock abbreviation "APT Medical" and stock code "688617." In the field of electrophysiological devices, APT Medical is the first manufacturer in China to obtain market access and enter clinical applications for electrophysiological electrode catheters, controllable radiofrequency ablation electrode catheters, and floating temporary pacemaker electrode catheters, breaking the monopoly of foreign products in this area. The company's electrophysiological electrode catheters and controllable radiofrequency ablation electrode catheters have been recognized as National Key New Products by the Ministry of Science and Technology and as Shenzhen self-innovative products by the Shenzhen Commission of Science, Industry, and Information Technology. The controllable radiofrequency ablation catheter has been designated as a high-tech product by the Guangdong Provincial Department of Science and Technology. The company’s three-dimensional cardiac electrophysiological mapping system employs internationally mainstream magnetic and electrical fusion positioning principles, innovatively integrating commonly used functions such as the three-dimensional mapping system, multichannel recorder, and stimulator in electrophysiological surgeries, greatly improving surgical efficiency and advancing the development of cardiac electrophysiological mapping systems to new heights. In the field of vascular interventional devices, the thin-walled sheath (vascular sheath set) is an exclusively China-produced product. The microcatheter (for coronary application) and adjustable valve catheter sheath (catheter sheath set) are the first domestically produced products of their kind in China to receive registration certificates. The anchoring balloon dilation catheter is an innovative medical device that uses balloon anchoring for catheter exchange within guiding catheters and is the first of its kind in China. The guidewire is the first China-produced guidewire to adopt a composite dual-core design and comes in various models to meet different clinical needs. The peripheral adjustable valve catheter sheath (catheter sheath set) is the only domestically produced product approved for marketing in China. APT Medical will always be committed to independent innovation and development in the field of minimally invasive cardiovascular interventions and will make outstanding contributions to promoting the global medical industry.